Drug Retention Rates of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients with Therapy-Induced Lymphopenia

Objectives: To determine whether drug-induced lymphocytopenia is associated with drug retention rates of JAKi (tofacitinib or baricitinib) in rheumatoid arthritis (RA) patients. Methods: Patients with RA who were initiated with tofacitinib (n = 38) or baricitinib (n = 74) between July 2015 and July...

Descripción completa

Detalles Bibliográficos
Autores principales: Temmoku, Jumpei, Miyata, Masayuki, Suzuki, Eiji, Sumichika, Yuya, Saito, Kenji, Yoshida, Shuhei, Matsumoto, Haruki, Fujita, Yuya, Matsuoka, Naoki, Asano, Tomoyuki, Sato, Shuzo, Watanabe, Hiroshi, Migita, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381502/
https://www.ncbi.nlm.nih.gov/pubmed/37510940
http://dx.doi.org/10.3390/jcm12144827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381502/
https://www.ncbi.nlm.nih.gov/pubmed/37510940
http://dx.doi.org/10.3390/jcm12144827

Ejemplares similares